Capital World Investors Gossamer Bio, Inc. Transaction History

Capital World Investors

  • $625 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$8.63 - $10.94 $861,774 - $1.09 Million
-99,858 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$8.3 - $13.59 $1.76 Million - $2.88 Million
-212,142 Reduced 67.99%
99,858 $966,000
Q1 2019

May 15, 2019
BUY
$17.58 - $23.97 $5.48 Million - $7.48 Million
312,000 New
312,000 $6.76 Million

Others Institutions Holding GOSS

# of Institutions
108
Shares Held
167M
Call Options Held
430K
Put Options Held
519K
View Full List

About Gossamer Bio, Inc.

GOSS Quotes by TradingView
  • Ticker GOSS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,954,000
  • Market Cap $65.8M
  • Description
  • Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...
More about GOSS
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email